CN110463988A - A kind of full nutrient formulation powder of the hypotonic type of low fat and preparation method thereof - Google Patents
A kind of full nutrient formulation powder of the hypotonic type of low fat and preparation method thereof Download PDFInfo
- Publication number
- CN110463988A CN110463988A CN201910671973.0A CN201910671973A CN110463988A CN 110463988 A CN110463988 A CN 110463988A CN 201910671973 A CN201910671973 A CN 201910671973A CN 110463988 A CN110463988 A CN 110463988A
- Authority
- CN
- China
- Prior art keywords
- parts
- vitamin
- powder
- low fat
- nutrient formulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 69
- 239000000203 mixture Substances 0.000 title claims abstract description 35
- 235000004213 low-fat Nutrition 0.000 title claims abstract description 21
- 235000015097 nutrients Nutrition 0.000 title claims abstract description 17
- 238000009472 formulation Methods 0.000 title claims abstract description 14
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 16
- 239000011707 mineral Substances 0.000 claims abstract description 16
- 235000010755 mineral Nutrition 0.000 claims abstract description 16
- 229940088594 vitamin Drugs 0.000 claims abstract description 14
- 229930003231 vitamin Natural products 0.000 claims abstract description 14
- 235000013343 vitamin Nutrition 0.000 claims abstract description 14
- 239000011782 vitamin Substances 0.000 claims abstract description 14
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 13
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims abstract description 12
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 12
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 12
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 claims abstract description 10
- 229930182816 L-glutamine Natural products 0.000 claims abstract description 10
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 8
- 210000002318 cardia Anatomy 0.000 claims abstract description 7
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 7
- 150000003839 salts Chemical class 0.000 claims abstract description 7
- 239000002562 thickening agent Substances 0.000 claims abstract description 7
- 238000005303 weighing Methods 0.000 claims abstract description 7
- 235000003599 food sweetener Nutrition 0.000 claims abstract description 5
- 239000003765 sweetening agent Substances 0.000 claims abstract description 5
- 239000000463 material Substances 0.000 claims description 19
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical group [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 14
- 239000005913 Maltodextrin Substances 0.000 claims description 11
- 229920002774 Maltodextrin Polymers 0.000 claims description 11
- 229940035034 maltodextrin Drugs 0.000 claims description 11
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 8
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 8
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 claims description 8
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 8
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 8
- 244000290333 Vanilla fragrans Species 0.000 claims description 8
- 235000009499 Vanilla fragrans Nutrition 0.000 claims description 8
- 235000012036 Vanilla tahitensis Nutrition 0.000 claims description 8
- VDTNNGKXZGSZIP-UHFFFAOYSA-N carbutamide Chemical compound CCCCNC(=O)NS(=O)(=O)C1=CC=C(N)C=C1 VDTNNGKXZGSZIP-UHFFFAOYSA-N 0.000 claims description 8
- 239000013078 crystal Substances 0.000 claims description 8
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 8
- 235000021388 linseed oil Nutrition 0.000 claims description 8
- 239000000944 linseed oil Substances 0.000 claims description 8
- 235000013336 milk Nutrition 0.000 claims description 8
- 239000008267 milk Substances 0.000 claims description 8
- 210000004080 milk Anatomy 0.000 claims description 8
- 238000007873 sieving Methods 0.000 claims description 8
- 229940083466 soybean lecithin Drugs 0.000 claims description 8
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 8
- 239000000230 xanthan gum Substances 0.000 claims description 8
- 235000010493 xanthan gum Nutrition 0.000 claims description 8
- 229920001285 xanthan gum Polymers 0.000 claims description 8
- 229940082509 xanthan gum Drugs 0.000 claims description 8
- 239000000654 additive Substances 0.000 claims description 7
- 230000000996 additive effect Effects 0.000 claims description 7
- 239000001103 potassium chloride Substances 0.000 claims description 7
- 235000011164 potassium chloride Nutrition 0.000 claims description 7
- 239000001509 sodium citrate Substances 0.000 claims description 7
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical group O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 7
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims description 6
- 244000068988 Glycine max Species 0.000 claims description 5
- 235000010469 Glycine max Nutrition 0.000 claims description 5
- 101710089165 Protein white Proteins 0.000 claims description 5
- 238000000926 separation method Methods 0.000 claims description 5
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 4
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 4
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 4
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 4
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 4
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 4
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 4
- 229930003268 Vitamin C Natural products 0.000 claims description 4
- 229930003316 Vitamin D Natural products 0.000 claims description 4
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 4
- 229930003427 Vitamin E Natural products 0.000 claims description 4
- 239000005862 Whey Substances 0.000 claims description 4
- 102000007544 Whey Proteins Human genes 0.000 claims description 4
- 108010046377 Whey Proteins Proteins 0.000 claims description 4
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 4
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 4
- 239000011575 calcium Substances 0.000 claims description 4
- 229910052791 calcium Inorganic materials 0.000 claims description 4
- 229960000304 folic acid Drugs 0.000 claims description 4
- 235000019152 folic acid Nutrition 0.000 claims description 4
- 239000011724 folic acid Substances 0.000 claims description 4
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 4
- 229910052742 iron Inorganic materials 0.000 claims description 4
- 239000011777 magnesium Substances 0.000 claims description 4
- 229910052749 magnesium Inorganic materials 0.000 claims description 4
- 229960003512 nicotinic acid Drugs 0.000 claims description 4
- 235000001968 nicotinic acid Nutrition 0.000 claims description 4
- 239000011664 nicotinic acid Substances 0.000 claims description 4
- 229940055726 pantothenic acid Drugs 0.000 claims description 4
- 235000019161 pantothenic acid Nutrition 0.000 claims description 4
- 239000011713 pantothenic acid Substances 0.000 claims description 4
- 239000011574 phosphorus Substances 0.000 claims description 4
- 229910052698 phosphorus Inorganic materials 0.000 claims description 4
- 229960003080 taurine Drugs 0.000 claims description 4
- 235000019155 vitamin A Nutrition 0.000 claims description 4
- 239000011719 vitamin A Substances 0.000 claims description 4
- 239000011691 vitamin B1 Substances 0.000 claims description 4
- 239000011715 vitamin B12 Substances 0.000 claims description 4
- 239000011726 vitamin B6 Substances 0.000 claims description 4
- 235000019154 vitamin C Nutrition 0.000 claims description 4
- 239000011718 vitamin C Substances 0.000 claims description 4
- 235000019166 vitamin D Nutrition 0.000 claims description 4
- 239000011710 vitamin D Substances 0.000 claims description 4
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 4
- 235000019165 vitamin E Nutrition 0.000 claims description 4
- 239000011709 vitamin E Substances 0.000 claims description 4
- 229940046009 vitamin E Drugs 0.000 claims description 4
- 229940045997 vitamin a Drugs 0.000 claims description 4
- 229940046008 vitamin d Drugs 0.000 claims description 4
- 239000011701 zinc Substances 0.000 claims description 4
- 229910052725 zinc Inorganic materials 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 239000011716 vitamin B2 Substances 0.000 claims description 3
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 claims description 2
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 claims description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 2
- 244000303965 Cyamopsis psoralioides Species 0.000 claims 1
- 244000046052 Phaseolus vulgaris Species 0.000 claims 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims 1
- FRYDSOYOHWGSMD-UHFFFAOYSA-N [C].O Chemical compound [C].O FRYDSOYOHWGSMD-UHFFFAOYSA-N 0.000 claims 1
- 239000002304 perfume Substances 0.000 claims 1
- 235000013599 spices Nutrition 0.000 claims 1
- 206010012735 Diarrhoea Diseases 0.000 abstract description 12
- 235000005911 diet Nutrition 0.000 abstract description 6
- 230000037213 diet Effects 0.000 abstract description 6
- 230000007661 gastrointestinal function Effects 0.000 abstract description 5
- 235000016709 nutrition Nutrition 0.000 description 16
- 230000035764 nutrition Effects 0.000 description 11
- 229920002907 Guar gum Polymers 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 239000000665 guar gum Substances 0.000 description 7
- 235000010417 guar gum Nutrition 0.000 description 7
- 229960002154 guar gum Drugs 0.000 description 7
- 230000000968 intestinal effect Effects 0.000 description 7
- 235000018102 proteins Nutrition 0.000 description 7
- 201000010099 disease Diseases 0.000 description 6
- 230000002496 gastric effect Effects 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 208000022559 Inflammatory bowel disease Diseases 0.000 description 5
- 210000000232 gallbladder Anatomy 0.000 description 5
- 210000001035 gastrointestinal tract Anatomy 0.000 description 5
- 235000013305 food Nutrition 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 208000011231 Crohn disease Diseases 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 201000001352 cholecystitis Diseases 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 230000003204 osmotic effect Effects 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 206010000060 Abdominal distension Diseases 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 206010019280 Heart failures Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 102000004407 Lactalbumin Human genes 0.000 description 2
- 108090000942 Lactalbumin Proteins 0.000 description 2
- 208000010718 Multiple Organ Failure Diseases 0.000 description 2
- 102000019280 Pancreatic lipases Human genes 0.000 description 2
- 108050006759 Pancreatic lipases Proteins 0.000 description 2
- 206010033645 Pancreatitis Diseases 0.000 description 2
- 206010041969 Steatorrhoea Diseases 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 210000000941 bile Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000002192 cholecystectomy Methods 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 210000004347 intestinal mucosa Anatomy 0.000 description 2
- 235000015263 low fat diet Nutrition 0.000 description 2
- 229940116369 pancreatic lipase Drugs 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 208000001162 steatorrhea Diseases 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 235000019605 sweet taste sensations Nutrition 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 102100025841 Cholecystokinin Human genes 0.000 description 1
- 101800001982 Cholecystokinin Proteins 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 208000037767 Gallbladder pain Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010020852 Hypertonia Diseases 0.000 description 1
- 208000034767 Hypoproteinaemia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010025476 Malabsorption Diseases 0.000 description 1
- 208000004155 Malabsorption Syndromes Diseases 0.000 description 1
- 208000034486 Multi-organ failure Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 239000003833 bile salt Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 229960004203 carnitine Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 229940107137 cholecystokinin Drugs 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 235000018823 dietary intake Nutrition 0.000 description 1
- 235000021196 dietary intervention Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 208000020694 gallbladder disease Diseases 0.000 description 1
- 208000001130 gallstones Diseases 0.000 description 1
- 238000011902 gastrointestinal surgery Methods 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 235000009200 high fat diet Nutrition 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 150000001261 hydroxy acids Chemical class 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000031891 intestinal absorption Effects 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000004130 lipolysis Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 208000029744 multiple organ dysfunction syndrome Diseases 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000003715 nutritional status Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 208000028719 osmotic diarrheal disease Diseases 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- IZTQOLKUZKXIRV-YRVFCXMDSA-N sincalide Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](N)CC(O)=O)C1=CC=C(OS(O)(=O)=O)C=C1 IZTQOLKUZKXIRV-YRVFCXMDSA-N 0.000 description 1
- 239000002893 slag Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000019710 soybean protein Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000017105 transposition Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pediatric Medicine (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention discloses full nutrient formulation powder of the hypotonic type of a kind of low fat and preparation method thereof, a kind of full nutrient formulation powder of the hypotonic type of low fat includes the carbohydrate that weight ratio is 40~55 parts, 1~7 part of Medium chain fatty, 22~38 parts of high-quality protein, 1~5 part of L-Glutamine, 0~7 part of thickener, 0~10 part of sweetener, 0~3.5 part of edible essence, 0~2 part of emulsifier, 0~1.5 part of vitamin premixed powder, 0~2.5 part of L-carnitine, 1~1.5 part of acidity regulator, 0~1 part of Cardia Salt and 1.5~2.5 parts of minerals premixed powder, a kind of preparation method of the full nutrient formulation powder of the hypotonic type of low fat includes a) weighing；B) it crushes；C) it premixes；D) total mix and e) dispense, formula have the characteristics that low fat, high protein and Hi CHO, poor suitable for gastrointestinal function, Yi Fasheng diarrhea patient and other need the crowd of low fat, hypotonic diet.
Description
[technical field]
The present invention relates to the technical field of Medical Nutritional food, the full nutrient formulation powder of the especially a kind of hypotonic type of low fat and its
The technical field of preparation method.
[background technique]
With the progress of modern medicine, EN support is increasingly by the attention of medical field.EN support has
Help guarantee that intestinal mucosa maintains normal secreting function, maintain gut barrier function, improve nutritional status, promotes body nitrogen flat
Weighing apparatus and maintenance immunoregulation, therefore become the preferred nutritional intervention method of Critical Ill Patient.
But for patient after gastrointestinal surgery, due to the seriousness and complexity of its disease, quite a few disease
There are the case where gastrointestinal tract does not tolerate, such as abdominal pain, diarrhea, abdominal distension and nausea and vomiting in regular meeting, therefore can not be according to reaching in the original plan
Dosage is fed to target to reach nutrition treatment purpose.It, can direct shadow if long-term existence enteral nutrition gastrointestinal tract does not tolerate
Enteron aisle normal physiological structure function is rung, function of intestinal mucosa barrier in patient is destroyed, leads to intestinal flora transposition, thus concurrent intestines source property endogenous toxic material
Plain mass formed by blood stasis eventually leads to Multiple Organ Failure Syndrome MODS generation.Fat is an important factor for influencing gastrointestinal toleration.
High fat diet easily causes stomach and does not tolerate, and as fat content > 20%, Incidence of Diarrhea is obviously increased.Bile acid concentration is lower than
Normal critical concentration value will lead to steatorrhea, and excess fatty acids can induce organic matter and the absorption of electrolyte and reduce, and cause to seep
Permeability diarrhea.Osmotic pressure is another main cause for influencing gastrointestinal toleration.If nutrient solution is hypertonicity diet, meeting
Stimulation large quantity of moisture enters gastrointestinal tract with dilute solution concentration, and enterocinesia is stimulated to accelerate and diarrhea occurs.
Inflammatory bowel disease refers to the unknown enteron aisle chronic inflammation disease of reason, mainly includes Crohn disease and exedens knot
Enteritis.Inflammatory bowel disease is easy to cause malnutritive, Hypoproteinemia and anaemia etc..Nutritional support treatment is inflammatory bowel disease
(IBD) it is digested to have obtained state for the important component treated, the especially effect in Crohn disease (CD) treatment
The extensive attention of section's medicine.The principle of nutrition treatment is to meet the nutritional need of patient, simultaneously by a variety of nutritional support modes
The stimulation of intestines caused by inflammation is reduced to minimum.Extension property bowel disease, often occurs steatorrhea, at this time the rouge of malabsorption
The hydroxy-acid derivative that fat acid and enteric bacteria generate, can stimulate colon secretion and aggravate symptom of diarrhea, therefore inflammatory bowel
Patient should select low fat diet.
Bile is firstly stored among gall-bladder by hepatic secretion, when body dietary intake, gallbladder contraction, and bile discharge,
It assists the lipolysis of bulky grain to be little particle, in order to which digestive ferment further digests.Human body is as occurred cholecystitis or gallbladder knot
When the gallbladder diseases such as stone, paracholia, fatty digestion and absorption will receive influence, and fat food can promote
The secretion of cholecystokinin makes gallbladder contraction, induces gallbladder pain, therefore gall-bladder class Disease is also required to low-fat nutrition food
Product.
Therefore, it needs a kind of patient poor for gastrointestinal function, Yi Fasheng diarrhea and other needs the hypotonic drink of low fat
The crowd of food, such as the patient of enteral nutrition is initially used after fasting, cholecystitis, gall stone, cholecystectomy, intestinal surgery are quasi-
A kind of low fat of standby, patient after gastrointestinal procedures, the patient for needing low-cholesterol diet etc., hypotonic type nutrient formulation powder.
[summary of the invention]
The object of the invention is to solve the problems of the prior art, propose a kind of full nutrient formulation powder of the hypotonic type of low fat and
Preparation method, formula have the characteristics that low fat, high protein and Hi CHO, and it is poor, easy to be suitable for gastrointestinal function
Occur diarrhea patient and other need the crowd of low fat, hypotonic diet.
To achieve the above object, the present invention is achieved through the following technical solutions:
A kind of full nutrient formulation powder of the hypotonic type of low fat, including weight ratio be 40~55 parts carbohydrate, 1~7 part
Medium chain fatty, 22~38 parts of high-quality protein, 1~5 part of L-Glutamine, 0~7 part of thickener, 0~10 part of sweet taste
Agent, 0~3.5 part of edible essence, 0~2 part of emulsifier, 0~1.5 part of vitamin premixed powder, 0~2.5 part left-handed
Carnitine, 1~1.5 part of acidity regulator, 0~1 part of Cardia Salt and 1.5~2.5 parts of minerals premixed powder.
Preferably, the carbohydrate is maltodextrin, the Medium chain fatty is medium chain triglyceride powder and powder
The mixture of one or both of linseed oil, the high-quality protein are one in PURE WHEY and soybean separation protein white powder
Kind or two kinds of mixture, the thickener are the mixture of one or both of guar gum and xanthan gum, the sweet taste
Agent is crystal diabetin, and the edible essence is the mixture of one or both of vanilla and milk powder essence, described
Emulsifier is soybean lecithin, and the vitamin premixed powder includes vitamin A, vitamin D, vitamin E, vitamin B1, niacin,
Pantothenic acid, vitamin B6, vitamin C, taurine, vitamin B2, folic acid and vitamin B12, the vitamin A based on its parts by weight
1120~1680 parts, 2.640~3.960 parts of vitamin D, 20580~30870 parts of vitamin E, vitamin B12816~
4224 parts, 27616~41424 parts of niacin, 7824~11736 parts of pantothenic acid, vitamin B62624~3936 parts, vitamin C
300000~450000 parts, 201600~302400 parts of taurine, vitamin B22432~3648 parts, folic acid 349.4~
524.2 part, vitamin B125.856~8.784 parts, the acidity regulator is sodium citrate, and the Cardia Salt is potassium chloride,
The minerals premixed powder includes calcium, phosphorus, iron, magnesium and zinc, 180.7~271.0 parts of calcium, phosphorus 93.34 based on its parts by weight
~140.0 parts, 4.952~7.429 parts of iron, 54.86~82.29 parts of magnesium, 2.899~4.349 parts of zinc.
A kind of preparation method of the full nutrient formulation powder of the hypotonic type of low fat, includes the following steps:
A) weigh: accurate weighing weight ratio be 40~55 parts of carbohydrate, 1~7 part of Medium chain fatty,
22~38 parts of high-quality protein, 1~5 part of L-Glutamine, 0~7 part of thickener, 0~10 part of sweetener,
0~3.5 part of edible essence, 0~2 part of emulsifier, 0~1.5 part of vitamin premixed powder, 0~2.5 part of left-handed meat
Alkali, 1~1.5 part of acidity regulator, 0~1 part of Cardia Salt and 1.5~2.5 parts of minerals premixed powder；
B) it crushes: after the bigger crushing material of granularity and will be sieved；
C) it premixes: the fewer material of additive amount is premixed and is sieved with portion carbohydrate；
D) total mix: all materials are subjected to total mix and merge sieving；
E) it dispenses: the material after total mix is distributed into the product of 30~50g/ packet.
Preferably, by the bigger crushing material of granularity to 30~50 mesh in the step b).
Beneficial effects of the present invention: formula of the invention has the characteristics that low fat, high protein and Hi CHO,
Middle fat is entirely Medium chain fatty, and gastrointestinal tolerant is good, has stronger specific aim, can be improved the tolerance of enteral nutrition preparation
Property, while providing fully nutrient, patient is made to be not susceptible to diarrhea, improve the nutrition condition of patient, improves the life of patient
Quality is very suitable for the patient of the poor easy generation diarrhea of gastrointestinal function or needs the crowd of low fat diet, such as inflammation
Property bowel disease, after the Pancreatitis Patients just transition of oral diet, patients with heart failure, fasting initially using the patient of enteral nutrition,
After cholecystitis, Patients with Cholelithiasis, cholecystectomy patient, obese people, intestinal surgery prepare patient and gastrointestinal procedures
Patient etc. integrally reconstitutes, saves conveniently, can better meet actual clinical application.
Feature and advantage of the invention will be described in detail by embodiment combination attached drawing.
[Detailed description of the invention]
Fig. 1 is the nutritional ingredient figure of embodiment one；
[specific embodiment]
Embodiment one:
The maltodextrin that 53.49 part of accurate weighing weight ratio, 2 parts of medium chain triglyceride powder, 18 parts of lactalbumin
Powder, 12 parts of soybean separation protein white powder, 5 parts of crystal diabetin, 3 parts of L-Glutamine, 0.22 part of guar gum, 0.18 part
Xanthan gum, 0.2 part of vanilla, 0.2 part of milk powder essence, 0.5 part of soybean lecithin, 0.1 part powder flax
Seed oil, 0.5 part of vitamin premixed powder, 2.1 parts of minerals premixed powder, 0.66 part of L-carnitine, 1.3 parts of lemon
Sour sodium and 0.55 part of potassium chloride.The bigger crystal diabetin of granularity, potassium chloride, L-carnitine and sodium citrate are crushed
It is sieved after to 40 mesh.By the fewer powder linseed oil of additive amount, vitamin premixed powder, guar gum and xanthan gum and portion
Maltodextrin is divided to be premixed and be sieved.By the fewer soybean lecithin of additive amount, minerals premixed powder, vanilla, ox
Milk powdered flavor and L-Glutamine are premixed and are sieved with part maltodextrin.Will premix sieving after two premixes,
Precomminution material after pulverizing and sieving carries out total mix with surplus material and merges sieving.Material after total mix is distributed into the production of 40g/ packet
Product.
Embodiment two:
The maltodextrin that 45 part of accurate weighing weight ratio, 2 parts of medium chain triglyceride powder, 16 parts of PURE WHEY,
10 parts of soybean separation protein white powder, 3 parts of crystal diabetin, 2 parts of L-Glutamine, 1 part of guar gum, 1 part of xanthan gum,
0.5 part of vanilla, 0.5 part of milk powder essence, 0.5 part of soybean lecithin, 0.5 part of powder linseed oil, 0.5 part
Vitamin premixed powder, 1.8 parts of minerals premixed powder, 1 part of L-carnitine, 1.2 parts of sodium citrate and 0.3 part
Potassium chloride.It is sieved after the bigger crystal diabetin of granularity, potassium chloride, L-carnitine and sodium citrate are crushed to 40 mesh.
By the fewer powder linseed oil of additive amount, vitamin premixed powder, guar gum and xanthan gum and part maltodextrin into
Row is premixed and is sieved.By the fewer soybean lecithin of additive amount, minerals premixed powder, vanilla, milk powder essence and
L-Glutamine is premixed and is sieved with part maltodextrin.After two premixes after being sieved will be premixed, pulverized and sieved
Precomminution material carries out total mix with surplus material and merges sieving.Material after total mix is distributed into the product of 40g/ packet.
Embodiment three:
The maltodextrin that 50 part of accurate weighing weight ratio, 4 parts of medium chain triglyceride powder, 20 parts of PURE WHEY,
14 parts of soybean separation protein white powder, 7 parts of crystal diabetin, 4 parts of L-Glutamine, 3 parts of guar gum, 2 parts of xanthan gum,
1 part of vanilla, 1.5 parts of milk powder essence, 1.5 parts of soybean lecithin, 1.5 parts of powder linseed oil, 1 part of dimension
Raw element premixed powder, 2.3 parts of minerals premixed powder, 2 parts of L-carnitine, 1.4 parts of sodium citrate and 0.7 part of chlorine
Change potassium.It is sieved after the bigger crystal diabetin of granularity, potassium chloride, L-carnitine and sodium citrate are crushed to 40 mesh.It will add
The fewer powder linseed oil of dosage, vitamin premixed powder, guar gum and xanthan gum and part maltodextrin carry out pre-
It mixes and is sieved.By the fewer soybean lecithin of additive amount, minerals premixed powder, vanilla, milk powder essence and L- paddy
Glutamine is premixed and is sieved with part maltodextrin.By the pre- powder after premixing two premixes after being sieved, pulverizing and sieving
Particle carries out total mix with surplus material and merges sieving.Material after total mix is distributed into the product of 40g/ packet.
Eating method: it is recommended that daily 6 packet, 1 is wrapped every time；
Reconstitute step:
1. 30mL or so warm water (50 DEG C) is added；2. pouring into the packet of this product 1 to stir evenly；3. warm water is reconstituted to 200mL i.e.
It can.
The present invention is hypotonic formula, and osmotic pressure is lower than 300mmol/L H2O, it is not easy to cause abdominal distension, diarrhea and other intestines
Road reaction, Intestinal Mucosal Injury in Patients Undergoing tolerance are more preferable.Forced for vitamins and minerals addition of the present invention, can take the photograph according to China's resident's nutrient
Enter guidelines addition multivitamin and minerals, a variety of diseases caused by lacking because of vitamin and mineral can be prevented and treated.Powder
The enteral nutrition preparation of dosage form is easy to save, and is easily adjusted the amount reconstituted and osmotic pressure, and using flexible is orally available.
The present invention is free of seitan, is low slag formula, can reduce the mechanical irritation to enteron aisle, reduces intestinal tympanites and diarrhea hair
Raw rate, the patient during being extremely suitable for that alimentary tract rest, function of intestinal canal is needed to restore, such as gastrointestinal function chump, Yi Fasheng diarrhea
Initially using enteral nutrition person, patients with inflammatory bowel disease, Pancreatitis Patients, just the transition of oral diet, heart failure are suffered from after person, fasting
The patients such as after person, intestinal surgery preparation patient, gastrointestinal procedures.
Present protein source is lactalbumin and soybean protein these high-quality proteins, it is necessary to amino acid content is abundant,
Amino acid pattern is easily absorbed and utilized close to human body, and it can be gastrointestinal tract mucosa that contained glutamine, which is conditionally essential amino acid,
Nutrition is provided.
The adipose-derived present invention is medium chain triglyceride powder, complete hydrolysis can be fatty acid and sweet under pancreatic lipase effect
Oil is rapidly absorbed, and is but not easy again three ester of synthetic glycerine after by small intestinal absorption, is suitble to the bad person of fat absorption, is easy to disappear
Change, can be absorbed in the case where pancreatic lipase and bile salt shortage.
Above-described embodiment is the description of the invention, is not limitation of the invention, after any pair of simple transformation of the present invention
Scheme all belong to the scope of protection of the present invention.
Claims (4)
1. a kind of full nutrient formulation powder of the hypotonic type of low fat, it is characterised in that: the carbon hydrate for being 40~55 parts including weight ratio
Object, 1~7 part of Medium chain fatty, 22~38 parts of high-quality protein, 1~5 part of L-Glutamine, 0~7 part of thickener, 0~
10 parts of sweetener, 0~3.5 part of edible essence, 0~2 part of emulsifier, 0~1.5 part of vitamin premixed powder, 0~
2.5 parts of L-carnitine, 1~1.5 part of acidity regulator, 0~1 part of Cardia Salt and 1.5~2.5 parts of minerals premix
Close powder.
2. a kind of full nutrient formulation powder of the hypotonic type of low fat as described in claim 1, it is characterised in that: the carbohydrate is
Maltodextrin, the Medium chain fatty are the mixture of one or both of medium chain triglyceride powder and powder linseed oil, institute
The mixture that high-quality protein is one or both of PURE WHEY and soybean separation protein white powder is stated, the thickener is Guar
The mixture of one or both of bean gum and xanthan gum, the sweetener are crystal diabetin, and the edible essence is that vanilla is fragrant
The mixture of essence and one or both of milk powder essence, the emulsifier are soybean lecithin, the vitamin premixing
Powder includes vitamin A, vitamin D, vitamin E, vitamin B1, niacin, pantothenic acid, vitamin B6, vitamin C, taurine, dimension life
Plain B2, folic acid and vitamin B12, 1120~1680 parts of vitamin A, vitamin D 2.640~3.960 based on its parts by weight
Part, 20580~30870 parts of vitamin E, vitamin B12816~4224 parts, 27616~41424 parts of niacin, pantothenic acid 7824~
11736 parts, vitamin B62624~3936 parts, 300000~450000 parts of vitamin C, taurine 201600~302400
Part, vitamin B22432~3648 parts, 349.4~524.2 parts of folic acid, vitamin B125.856~8.784 parts, the acidity tune
Section agent is sodium citrate, and the Cardia Salt is potassium chloride, and the minerals premixed powder includes calcium, phosphorus, iron, magnesium and zinc, by it
180.7~271.0 parts of parts by weight meter calcium, 93.34~140.0 parts of phosphorus, 4.952~7.429 parts of iron, magnesium 54.86~82.29
Part, 2.899~4.349 parts of zinc.
3. a kind of preparation method of the full nutrient formulation powder of the hypotonic type of low fat, it is characterised in that include the following steps:
A) weigh: accurate weighing weight ratio is 40~55 parts of carbohydrate, 1~7 part of Medium chain fatty, 22~38 parts
High-quality protein, 1~5 part of L-Glutamine, 0~7 part of thickener, 0~10 part of sweetener, 0~3.5 part of edible perfume (or spice)
Essence, 0~2 part of emulsifier, 0~1.5 part of vitamin premixed powder, 0~2.5 part of L-carnitine, 1~1.5 part of acidity
Regulator, 0~1 part of Cardia Salt and 1.5~2.5 parts of minerals premixed powder；
B) it crushes: after the bigger crushing material of granularity and will be sieved；
C) it premixes: the fewer material of additive amount is premixed and is sieved with portion carbohydrate；
D) total mix: all materials are subjected to total mix and merge sieving；
E) it dispenses: the material after total mix is distributed into the product of 30~50g/ packet.
4. a kind of full nutrient formulation powder of the hypotonic type of low fat as claimed in claim 3 and preparation method thereof, it is characterised in that: described
By the bigger crushing material of granularity to 30~50 mesh in step b).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910671973.0A CN110463988A (en) | 2019-07-24 | 2019-07-24 | A kind of full nutrient formulation powder of the hypotonic type of low fat and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910671973.0A CN110463988A (en) | 2019-07-24 | 2019-07-24 | A kind of full nutrient formulation powder of the hypotonic type of low fat and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110463988A true CN110463988A (en) | 2019-11-19 |
Family
ID=68508858
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910671973.0A Pending CN110463988A (en) | 2019-07-24 | 2019-07-24 | A kind of full nutrient formulation powder of the hypotonic type of low fat and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110463988A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112890179A (en) * | 2021-03-01 | 2021-06-04 | 成都尚医信息科技有限公司 | Semi-solidified nutrient for solving enteral nutrition intolerance and preparation method thereof |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105054025A (en) * | 2015-08-09 | 2015-11-18 | 青岛大学附属医院 | Low-fat low-osmosis low-residue type enteral nutritional powder for patients with inflammatory bowel diseases |
| CA2944529A1 (en) * | 2014-08-07 | 2016-02-11 | Mingfu Lu | Complete nutritional powder and preparation method thereof |
| CN106616998A (en) * | 2016-12-30 | 2017-05-10 | 北京康比特体育科技股份有限公司 | Nutrition meal replacement composition and application thereof |
| CN107252109A (en) * | 2017-07-10 | 2017-10-17 | 北京素维生物科技有限公司 | Function nutrition hardening agent composition and preparation method thereof |
| CN107307390A (en) * | 2017-07-10 | 2017-11-03 | 北京素维生物科技有限公司 | Function nutrition hardening agent composition and preparation method |
| CN107343657A (en) * | 2017-06-05 | 2017-11-14 | 深圳市捷利康生物科技有限公司 | High fat diet formula powder |
| CN108968046A (en) * | 2018-07-25 | 2018-12-11 | 哈尔滨拜仑斯特临床营养有限公司 | A kind of special medicine purposes full nutrition formula food and preparation method thereof |
-
2019
- 2019-07-24 CN CN201910671973.0A patent/CN110463988A/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2944529A1 (en) * | 2014-08-07 | 2016-02-11 | Mingfu Lu | Complete nutritional powder and preparation method thereof |
| CN105054025A (en) * | 2015-08-09 | 2015-11-18 | 青岛大学附属医院 | Low-fat low-osmosis low-residue type enteral nutritional powder for patients with inflammatory bowel diseases |
| CN106616998A (en) * | 2016-12-30 | 2017-05-10 | 北京康比特体育科技股份有限公司 | Nutrition meal replacement composition and application thereof |
| CN107343657A (en) * | 2017-06-05 | 2017-11-14 | 深圳市捷利康生物科技有限公司 | High fat diet formula powder |
| CN107252109A (en) * | 2017-07-10 | 2017-10-17 | 北京素维生物科技有限公司 | Function nutrition hardening agent composition and preparation method thereof |
| CN107307390A (en) * | 2017-07-10 | 2017-11-03 | 北京素维生物科技有限公司 | Function nutrition hardening agent composition and preparation method |
| CN108968046A (en) * | 2018-07-25 | 2018-12-11 | 哈尔滨拜仑斯特临床营养有限公司 | A kind of special medicine purposes full nutrition formula food and preparation method thereof |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112890179A (en) * | 2021-03-01 | 2021-06-04 | 成都尚医信息科技有限公司 | Semi-solidified nutrient for solving enteral nutrition intolerance and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107343657B (en) | Ketogenic diet formula powder | |
| CN101061860B (en) | Leucine-rich nutritional compositions | |
| JP3251287B2 (en) | Calcium and trace mineral supplies | |
| DE60310934T2 (en) | COMPOSITION REQUIRING SATURATION FEELING | |
| CN107319525A (en) | One kind fat-reducing fat reducing tailored version clinical nutrition formula and preparation method thereof | |
| US20040253227A1 (en) | Perioperative multivitamin protein beverage and additive for use in preparing an individual for fast surgical recovery | |
| CN1052865C (en) | Nutrient composition | |
| JPWO2003022288A1 (en) | Nutritional composition for controlling blood sugar level | |
| US20110081400A1 (en) | Nutritional composition for bariatric surgery patients | |
| US20040253295A1 (en) | Perioperative multivitamin protein bar for use in preparing an individual for fast surgical recovery | |
| CN111084389A (en) | Dietary fiber composite powder and preparation method thereof | |
| CN103976116A (en) | Phospholipid tabletting candy and preparation method thereof | |
| CN108077911A (en) | A kind of epileptic's tailored version clinical nutrition formula and preparation method thereof | |
| JP2004168704A (en) | Preparation for muscle augmentation | |
| CN110074397A (en) | A kind of upgrowth and development of children tailored version clinical nutrition formula and preparation method thereof | |
| JP2011004702A (en) | Dietary fiber-containing nutrient composition | |
| CN103404865A (en) | Nutritional meal replacement powder with effect of reducing weight and fat and preparation method thereof | |
| JP2008247748A (en) | Nutritive composition for dialysis patient | |
| WO2014204382A1 (en) | Administration of a food composition product | |
| JP2000300194A (en) | Nutritional rice gruel | |
| CN114208989A (en) | Ketogenic meal replacement nutrition powder solid beverage and preparation method thereof | |
| EP1410722A1 (en) | Weight loss kit and method for losing weight | |
| CN110463988A (en) | A kind of full nutrient formulation powder of the hypotonic type of low fat and preparation method thereof | |
| CN108541912A (en) | A kind of anti-oxidant blood-fat reducing composition and its preparation method and application | |
| RU2525338C2 (en) | Instant functional food product |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20191119 |